MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients

Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie

dc.contributor.author	Eigentler, Thomas
dc.date.accessioned	2019-09-03T10:37:11Z
dc.date.available	2019-09-03T10:37:11Z
dc.date.issued	2018
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/92294
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2018.04.010	de_DE
dc.subject.ddc	610	de_DE
dc.title	MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_02097
utue.publikation.seiten	10-16	de_DE
utue.personen.roh	Kirchberger, Michael Constantin
utue.personen.roh	Ugurel, Selma
utue.personen.roh	Mangana, Johanna
utue.personen.roh	Heppt, Markus Valentin
utue.personen.roh	Eigentler, Thomas Kurt
utue.personen.roh	Berking, Carola
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Schuler, Gerold
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Heinzerling, Lucie
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	98	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE